Tag: trastuzumab
Novartis: Favorable opinion for a trastuzumab biosimilar
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Novartis: favorable opinion for a trastuzumab biosimilar
(CercleFinance.com) – Sandoz, the generic subsidiary of Novartis, announced Monday that the committee of experts (CHMP) of the European Medicines Agency (EMA) had issued a favorable opinion concerning its marketing…
Novartis: application for approval of Sandoz for trastuzumab with the EMA
Zurich (awp) – Sandoz takes a further step towards the commercialization of the biosimilar trastuzumab in the European Union. The Novartis subsidiary has filed an application for marketing authorization for…